Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
Medical Device

NRW (North Rhine Westphalia) parties split on embryonic stem cell imports

This article was originally published in Clinica

  • News

Executive Summary

The stem cell research issue has provoked differences of opinion have arisen between the Green (Bundnis90/Die Grunen) and Social democratic (SPD) coalition partners in the German state of North Rhine Westphalia (NRW). In light of NRW President Wolfgang Clement's support for the importing of embryonic stem cells from Israel (see Clinica No 962, p 5), a two hour meeting of the coalition partners in Dusseldorf was used as a forum to define the various positions.

Table

View full table

Topics

Tags:
Medical Device
Latest Headlines

MHRA Sets Out Summer Schedule Of Medtech Regulatory Milestones

Apple Watch Feature Qualified As FDA Device Development Tool

Expert Proposes AI Device Reimbursement Model ‘Like Netflix’

Robotic-Assisted Treatment For Enlarged Prostate Shows Promising Results

See All
UsernamePublicRestriction

Register

MT071773

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By